Keywords
poisoning
pediatrics
How to Cite
Abstract
Antidepressants are agents that cause significant morbidity and mortality with important toxicity particularly on cardiovascular and neurological systems, which is mainly based on their pharmacology and is that determines specific treatment. Unfortunately, children are vulnerable population because the increase in psychiatric disorders which are treated with these drugs. The purpose of this article is to review the pharmacokinetics, clinical presentation and treatment of acute poisoning with tricyclic antidepressants.
Giles HM. Imipramine poisoning in childhood. BMJ.1963;2:844-6.
Simon FA, Treuting JJ. Nonaccidental poisoning in a two-month-old child. Clin Toxicol. 1981;18:37-40.
Lai MW, Klein-Schwartz W, Rodgers GC, et al. 2005 Annual report of the American Association of Poison Control Centers’ national poisoning and exposure database. Clin Toxicol. 2006;44:803-932.
Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Reid N, Youniss J, Flanagan A, Wruk KM. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2005;23:589-666.
Hollister L. Antidepressants. In: Katzung BG. Basic and clinical pharmacology. 3rd ed. Connecticut: Appleton and Lange; 1987. pp. 327-35.
Dziukas LJ, Vohra J. Tricyclic antidepressant poisoning. Med J Aust.
;154:344-50.
Jarvis MR. Clinical pharmacokinetics of tricyclic antidepressant overdose. Psychopharmacol Bull. 1991;27:541-50.
Woolf A, Erdman A, Lewis N, Caravati M, et al. Tricyclic antidepressant poisoning: an evidence-based consensus guideline
for out-of-hospital management. Clin Toxicol. 2007;45:203-33.
Vohra J, Burrows G, Hunt D, et al. The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol. 1975;3:219-27.
Baldessarini RJ. Drugs and the treatment of psychiatric disorders: depression and anxiety disorders. In: Hardman JG, Limbird LE, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. pp. 447-83.
Marx J, Adams J, Walls R. Rosen’s emergency medicine: concepts and clinical practice. 6th ed. Philadephia: Mosby; 2006. Capítulo 149.
Swartz CM, Sherman A. The treatment of tricyclic antidepressant overdose with repeated charcoal. J Clin Psychopharmacol. 1984;4:336-40.
Goel KM, Shanks RA. Amitriptyline and imipramine poisoning in children. Br Med J. 1974;1:261-3.
Kerr G, McGuYe A, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18:236-41.
Merigian KS, Hedges JR, Kaplan LA, et al. Plasma catecholamine levels in cyclic antidepressant overdose. J Toxicol Clin Toxicol. 1991;29:177-90.
Smith MS. Amitriptyline ophthalmoplegia. Ann Intern Med. 1979;91:793.
Roberge RJ, Martin TG, Hodgman M, Benitez JG. Acute chemical pancreatitis associated with a tricyclic antidepressant (clomipramine) overdose. J Toxicol Clin Toxicol. 1994; 32:425-9.
Starkey IR, Lawson AAH. Poisoning with tricyclic and related antidepressants: a ten-year review. Q J Med- 1980;49:33-49.
Ellison DW, Pentel PR. Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med. 1989;7:5.
Groleau G, Jotte R, Barish R. The electrocardiographic manifestations of cyclic antidepressant therapy and overdose: a
review. J Emerg Med. 1990;8:597-605.
Liebelt E. An update on antidepressant toxicity: an evolution of unique tox icities to master. Clin Ped Emerg Med. 2008;9:24-34.
Boehnert MT, Lovejoy FH Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med. 1985;313:474-9.
Hulten BA, Adams R, Askenasi R, et al. Predicting severity of tricyclic antidepressant overdose. J Toxicol Clin Toxicol. 1992;30:161-70.
Emerman CL, Connors AF, Burma GM. Level of consciousness as a predictor of complications following tricyclic overdose. Ann Emerg Med. 1987;16:326-30.
Singh N, Singh HK, Khan IA. Serial electrocardiographic changes as a predictor of cardiovascular toxicity in acute tricyclic antidepressant overdose. Am J Ther. 2002;9:75-9.
Thanacoody R, Thomas S. Tricyclic antidepressant poisoning cardiovascular toxicity. Toxicol Rev. 2005;24(3):205-14.
Liisanantti J, Kaukoranta P, Martikainen M, et al. Aspiration pneumonia following self-poisoning. Resuscitation. 2003;56:49-53.
Hedges JR, Otten EJ, Schroeder TJ, et al. Correlation of initial amitriptyline concentration reduction with activated charcoal therapy in overdose patients. Am J Emerg Med. 1987;5:48-51.
Hulten BA, Adams R, Askenasi R. Activated charcoal in tricyclic antidepressant poisoning. Hum Toxicol. 1988;7:307-10.
Shannon M, Liebelt E. Toxicology reviews: Targeted management strategies for cardiovascular toxicity from tricyclic antidepressant overdose: The pivotal role for alkalinization and sodium loading.
Pediatr Emerg Care. 1998;14:293.
Body R, Bartram T, Azam F, Mackway-Jones K. Guidelines in Emergency Medicine Network (GEMNet): guideline for the management of tricyclic antidepressant overdose. Emerg Med J.
;28:347-68.
Blackman K, Brown SGA, Wilkes GJ. Plasma alkalinization for tricyclic antidepressant toxicity: a systematic review. Emerg Med. 2001;13:204-10.
Seger DL, Hantsch C, Zavoral T, et al. Variability of recommendations for serum alkalinization in tricyclic antidepressant
overdose: a survey of US poison center medical directors. J Toxicol Clin Toxicol. 2003;41:331-8.
McCabe JL, Cobaugh DJ, Menegazzi J, et al. Experimental tricyclic antidepressant toxicity: a randomized, controlled comparison of hypertonic saline solution, sodium bicarbonate and hyperventilation.
Ann Emerg Med. 1998;32:329-33.
McKinney P, Rasmussen R. Reversal of severe tricyclic antidepressant-induced cardiotoxicity with intravenous hypertonic
saline solution. Ann Emerg Med. 2003;42:20-4.
Liebelt E. An update on antidepressant toxicity: an evolution of unique toxicities to master. Clin Ped Emerg Med. 2008;9:24-34.
Pentel P, Peterson C. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med. 1980;9:588.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.